TimesSquare Capital Management’s Ascendis Pharma A/S Ordinary Share ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $74.8M | Sell |
|
|||||
|
2024
Q2 | $81.3M | Buy |
|
|||||
|
2024
Q1 | $87M | Sell |
|
|||||
|
2023
Q4 | $99.9M | Sell |
|
|||||
|
2023
Q3 | $78.9M | Buy |
|
|||||
|
2023
Q2 | $68.5M | Sell |
|
|||||
|
2023
Q1 | $91.4M | Buy |
|
|||||
|
2022
Q4 | $96.6M | Buy |
|
|||||
|
2022
Q3 | $66.1M | Buy |
|
|||||
|
2022
Q2 | $41.8M | Sell |
|
|||||
|
2022
Q1 | $58.7M | Sell |
|
|||||
|
2021
Q4 | $73.3M | Sell |
|
|||||
|
2021
Q3 | $93.1M | Buy |
|
|||||
|
2021
Q2 | $47.8M | Sell |
|
|||||
|
2021
Q1 | $60.1M | Buy |
|
|||||
|
2020
Q4 | $72.2M | Buy |
|
|||||
|
2020
Q3 | $66.6M | Buy |
|
|||||
|
2020
Q2 | $34M | Buy |
|